Regulatory Investigations In July 2023, the Icelandic Medicines Agency received reports about suicidal ideation in patients using GLP-1s, and the European Medicines Agency (EMA) initiated a review of a possible association between GLP-1 usage and suicidal ideation
Cotargeting proteins involved in glutamine metabolism and the stress response under conditions of glutamine depletion would therefore be a promising therapeutic strategy for overcoming adaptive/resistance mechanisms in cancer cells
Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis
The role of tirzepatide, dual GIP and GLP-1 receptor agonist, in the management of type 2 diabetes
As patients seek to manage this issue, they often look for effective sleeve gastrectomy weight regain treatment options
According to iColour, the balm which is applied to the skin underneath the eye, not directly in the eye works "by inhibiting melanin production," thereby changing your eye color over time
